William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 1,990 shares at $149.38 ($297K) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Seasonal sale ($297k) by Executive Chairman — this insider has traded NVCR in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.38 | 995 | $149K | 50.0% |
| 2 | $149.38 | 995 | $149K | 50.0% |
| Total | $149.38 avg | 1,990 | $297K | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |